Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
triamcinolone (kenalog) (1 trial)
bevacizumab (avastin) (1 trial)
Macular Degeneration (Phase 3)
Trials (2 total)
Trial APIs (2 total)